# Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial

> **NCT07371897** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 154 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma HNSCC

## Interventions

- **DRUG:** Docetaxel and Cisplatin
- **DRUG:** Toripalimab

## Key facts

- **NCT ID:** NCT07371897
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07371897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07371897, "Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07371897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*